Satish Ramalingam

2.3k total citations
65 papers, 1.7k citations indexed

About

Satish Ramalingam is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Satish Ramalingam has authored 65 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 19 papers in Cancer Research and 17 papers in Oncology. Recurrent topics in Satish Ramalingam's work include RNA modifications and cancer (13 papers), RNA Research and Splicing (12 papers) and MicroRNA in disease regulation (10 papers). Satish Ramalingam is often cited by papers focused on RNA modifications and cancer (13 papers), RNA Research and Splicing (12 papers) and MicroRNA in disease regulation (10 papers). Satish Ramalingam collaborates with scholars based in United States, India and France. Satish Ramalingam's co-authors include Shrikant Anant, Dharmalingam Subramaniam, Courtney W. Houchen, Gopalan Natarajan, Randal May, Sripathi M. Sureban, Brian K. Dieckgraefe, R. Arulmozhi, Siranjeevi Ravichandran and N. Abirami and has published in prestigious journals such as Gastroenterology, PLoS ONE and Journal of Applied Physics.

In The Last Decade

Satish Ramalingam

60 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satish Ramalingam United States 21 1.0k 421 367 164 150 65 1.7k
Ansar Karimian Iran 23 1.5k 1.4× 563 1.3× 466 1.3× 169 1.0× 74 0.5× 38 2.4k
Shuyan Liu China 25 1.1k 1.1× 387 0.9× 309 0.8× 144 0.9× 81 0.5× 112 2.0k
Mohsen Rashidi Iran 24 996 1.0× 488 1.2× 320 0.9× 166 1.0× 65 0.4× 96 1.9k
Patrícia Severino Brazil 25 774 0.8× 320 0.8× 495 1.3× 190 1.2× 76 0.5× 74 1.9k
Haiyang Yu China 23 867 0.9× 327 0.8× 210 0.6× 166 1.0× 80 0.5× 92 1.9k
Reza Nedaeinia Iran 19 942 0.9× 650 1.5× 345 0.9× 239 1.5× 86 0.6× 52 1.7k
Tongcun Zhang China 29 1.4k 1.4× 626 1.5× 441 1.2× 183 1.1× 76 0.5× 118 2.4k
Tianhui Hu China 31 1.4k 1.4× 439 1.0× 364 1.0× 82 0.5× 297 2.0× 111 2.7k
Qiwei Jiang China 27 1.1k 1.1× 389 0.9× 421 1.1× 132 0.8× 75 0.5× 61 1.9k

Countries citing papers authored by Satish Ramalingam

Since Specialization
Citations

This map shows the geographic impact of Satish Ramalingam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satish Ramalingam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satish Ramalingam more than expected).

Fields of papers citing papers by Satish Ramalingam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satish Ramalingam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satish Ramalingam. The network helps show where Satish Ramalingam may publish in the future.

Co-authorship network of co-authors of Satish Ramalingam

This figure shows the co-authorship network connecting the top 25 collaborators of Satish Ramalingam. A scholar is included among the top collaborators of Satish Ramalingam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satish Ramalingam. Satish Ramalingam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ramalingam, Satish, et al.. (2025). Identification of Flavonoid-based Hypoxia-inducible Factor-2 Alpha Inhibitors for the Treatment of Breast Cancer– In silico and In vitro Evidence. Anti-Cancer Agents in Medicinal Chemistry. 25(17). 1359–1368.
3.
Ramalingam, Satish, et al.. (2024). RNA binding proteins in cancer chemotherapeutic drug resistance. Frontiers in Cell and Developmental Biology. 12. 1308102–1308102. 4 indexed citations
5.
Mohideen, Sahabudeen Sheik, et al.. (2023). Exosomes Derived from Metastatic Colon Cancer Cells Induced Oncogenic Transformation and Migratory Potential of Immortalized Human Cells. International Journal of experimental research and review. 36. 37–46. 4 indexed citations
6.
Madhavan, Thirumurthy, et al.. (2022). Morin inhibits colon cancer stem cells by inhibiting PUM1 expression in vitro. Medical Oncology. 39(12). 251–251. 13 indexed citations
7.
Ramalingam, Satish, et al.. (2022). Influence of Long Non-Coding RNA in the Regulation of Cancer Stem Cell Signaling Pathways. Cells. 11(21). 3492–3492. 10 indexed citations
8.
Subramaniam, Dharmalingam, Sivapriya Ponnurangam, Satish Ramalingam, et al.. (2021). Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis. Cells. 10(7). 1607–1607. 11 indexed citations
9.
Sivaramakrishnan, V., et al.. (2021). The impact of fusion genes on cancer stem cells and drug resistance. Molecular and Cellular Biochemistry. 476(10). 3771–3783. 9 indexed citations
10.
Ramalingam, Satish, et al.. (2021). RNA binding protein PUM1 promotes colon cancer cell proliferation and migration. International Journal of Biological Macromolecules. 174. 549–561. 15 indexed citations
11.
Palaniyandi, Kanagaraj, et al.. (2020). Exosomes isolated from two different cell lines using three different isolation techniques show variation in physical and molecular characteristics. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1863(2). 183490–183490. 78 indexed citations
12.
Ramalingam, Satish, Selvaraj Jayaraman, Ganesh Munuswamy‐Ramanujam, et al.. (2020). Tamoxifen induces stem-like phenotypes and multidrug resistance by altering epigenetic regulators in ERα+ breast cancer cells. PubMed. 7. 20–20. 8 indexed citations
13.
Ramamoorthy, Prabhu, Sufi M. Thomas, Gaurav Kaushik, et al.. (2019). Metastatic Tumor-in-a-Dish, a Novel Multicellular Organoid to Study Lung Colonization and Predict Therapeutic Response. Cancer Research. 79(7). 1681–1695. 44 indexed citations
14.
Ponnurangam, Sivapriya, Joshua M.V. Mammen, Satish Ramalingam, et al.. (2012). Honokiol in Combination with Radiation Targets Notch Signaling to Inhibit Colon Cancer Stem Cells. Molecular Cancer Therapeutics. 11(4). 963–972. 93 indexed citations
15.
Kaushik, Gaurav, et al.. (2012). Honokiol induces cytotoxic and cytostatic effects in malignant melanoma cancer cells. The American Journal of Surgery. 204(6). 868–873. 41 indexed citations
16.
Ramalingam, Satish. (2012). Reduced Expression of RNA Binding Protein CELF2, a Putative Tumor Suppressor Gene in Colon Cancer. PubMed. 1(1). 27–27. 44 indexed citations
17.
Subramaniam, Dharmalingam, Satish Ramalingam, David C. Linehan, et al.. (2011). RNA Binding Protein CUGBP2/CELF2 Mediates Curcumin-Induced Mitotic Catastrophe of Pancreatic Cancer Cells. PLoS ONE. 6(2). e16958–e16958. 63 indexed citations
18.
Subramaniam, Dharmalingam, Satish Ramalingam, Randal May, et al.. (2008). Gastrin-Mediated Interleukin-8 and Cyclooxygenase-2 Gene Expression: Differential Transcriptional and Posttranscriptional Mechanisms. Gastroenterology. 134(4). 1070–1082. 55 indexed citations
19.
Ramalingam, Satish, Gopalan Natarajan, Dharmalingam Subramaniam, et al.. (2008). Novel intestinal splice variants of RNA-binding protein CUGBP2: isoform-specific effects on mitotic catastrophe. American Journal of Physiology-Gastrointestinal and Liver Physiology. 294(4). G971–G981. 24 indexed citations
20.
Ramalingam, Satish, et al.. (1982). Characteristics, Riemann Invariants, and Plane Strain Plasticity. Journal of Engineering for Industry. 104(3). 265–271. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026